Evidence map›Paper›PMID 31273299›Full record

ArticleCell death and differentiation2020

ATF3 promotes erastin-induced ferroptosis by suppressing system Xc

Liyuan Wang, Yichen Liu, Tingting Du, Heng Yang, Lei Lei, Mengqi Guo, Han-Fei Ding, Junran Zhang, Hongbo Wang, Xiaoguang Chen and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Cell death and differentiation, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 478 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
478citing papers in PubMed, 1 pooled it
44.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

478 citing papers in PubMed, 1 synthesis or guideline pooled it, 785 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

418 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 2 countries.

Liyuan WangInstitute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Yichen LiuHarbin Commercial University, Heilongjiang, China.
Tingting DuInstitute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Heng YangGeorgia Cancer Center, Augusta University, Augusta, GA, USA.
Lei LeiSchool of Pharmacy, Yantai University, Yantai, Shandong Province, China.
Mengqi GuoSchool of Pharmacy, Yantai University, Yantai, Shandong Province, China.
Han-Fei DingGeorgia Cancer Center, Augusta University, Augusta, GA, USA.
Junran ZhangDepartment of Radiation Oncology, Ohio State University, Columbus, OH, USA.
Hongbo WangSchool of Pharmacy, Yantai University, Yantai, Shandong Province, China.
Xiaoguang ChenInstitute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Chunhong YanGeorgia Cancer Center, Augusta University, Augusta, GA, USA. cyan@augusta.edu.
Chinese Academy of Medical Sciences & Peking Union Medical College · CNYantai University · CNAugusta University Health · USAugusta University · USHarbin University of Commerce · CNThe Ohio State University · US

Funding

RNA epigenetic regulation of cancer metabolismR01CA190429 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI HAN-FEI DING · 2014 to 2026
$3.7M
The Role of ATF3 in the DNA Damage ResponseR01CA139107 · NCI · AUGUSTA UNIVERSITY · PI YAN, CHUNHONG · 2010 to 2015
$1.2M
NCI NIH HHS R01 CA139107NCI NIH HHS R01 CA190429
6 · The paper itself

Abstract

The amino acid antiporter system Xc

Indexed as

Activating Transcription Factor 3Amino Acid Transport System y+Antineoplastic AgentsFerroptosisHumansLipid PeroxidationPiperazinesTumor Cells, CulturedActivating Transcription Factor 3Amino Acid Transport System y+Antineoplastic AgentsATF3 protein, humanerastinPiperazinesSLC7A11 protein, human

Identifiers

PMID31273299
PMCPMC7206049
OpenAlexW2954162996

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.